Decline in Quantitative Serum HBsAg Level during Consolidation Therapy Following HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir

被引：0
|
作者：
Su, Wen-Pang [1 ]
Peng, Cheng-Yuan [1 ]
Lai, Hsueh-Chou [1 ]
Lin, Chia-Hsin [1 ]
Chuang, Po-Heng [1 ]
Chen, Sheng-Hung [1 ]
机构：
[1] China Med Univ Hosp, Taichung, Taiwan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1875
引用
收藏
页码：1102A / 1103A
页数：2
相关论文
共 50 条
  • [41] EVALUATION OF THE EFFICACY OF ENTECAVIR VERSUS ADEFOVIR IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS THERAPY AT 96 WEEKS
    Sun, Aimin
    Cheng, Haowei
    Zhao, Liqun
    Yang, Huiyu
    Yang, Guojie
    HEPATOLOGY, 2010, 52 (04) : 550A - 550A
  • [42] A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
    Fen-Yu Ren
    World Journal of Gastroenterology, 2007, (31) : 4264 - 4267
  • [43] Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series
    d'Ettorre, G.
    Barbarini, G.
    Corti, F.
    Gobber, M.
    Pastecchia, C.
    Ricci, G. L.
    Siciliano, M.
    Annicchiarico, B. E.
    Vullo, V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (06) : 551 - 554
  • [44] INTRAHEPATIC HBSAG REDUCTION AFTER PEGINTERFERON TREATMENT IN HBEAG NEGATIVE AND HBEAG POSITIVE CHRONIC HEPATITIS B IS ASSOCIATED WITH SERUM HBSAG DECLINE
    Arends, P.
    Rijckborst, V.
    Sonneveld, M.
    Hansen, B.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S196 - S196
  • [45] A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
    Ren, Fen-Yu
    Piao, Dong-Ming
    Piao, Xi-Xu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (31) : 4264 - 4267
  • [46] Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B
    Huang, Yi-Jie
    Yang, Sheng-Shun
    Yeh, Hong-Zen
    Chang, Chi-Sen
    Peng, Yen-Chun
    PLOS ONE, 2019, 14 (08):
  • [47] Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients
    Ma, Hui
    Yang, Rui-feng
    Wei, Lai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (09) : 1498 - 1506
  • [48] Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment
    Zhao, Xiang-An
    Wang, Jian
    Liu, Jiacheng
    Chen, Guangmei
    Yan, Xiaomin
    Jia, Bei
    Yang, Yue
    Liu, Yong
    Gu, Da
    Zhang, Zhaoping
    Xiang, Xiaoxing
    Huang, Rui
    Wu, Chao
    ANTIVIRAL RESEARCH, 2021, 193
  • [49] Predictors of HBeAg loss in HBeAg-positive patients with chronic hepatitis B during treatment with tenofovir alafenamide or tenofovir disoproxil fumarate
    Pan, Calvin Q.
    Li, Michael Kin Kong
    Lee, Kwan Sik
    Balabanska, Rozalina I.
    Flaherty, John F.
    Kim, Kyungpil
    Myers, Robert P.
    Subramanian, Mani
    Abdurakhmanov, Djamal
    Ma, Mang M.
    Bae, Ho
    Agarwal, Kosh
    HEPATOLOGY, 2016, 64 : 931A - 931A
  • [50] QUANTITATIVE HBSAG AND HBEAG ASSAYS IN THE PREDICTION OF THE VIROLOGIC RESPONSE TO ENTECAVIR IN PATIENTS WITH CHRONIC HEPATITIS B
    Lee, Jung Min
    Kim, Hyon Suk
    Ahn, Sang Hoon
    Park, Hana
    Kim, Do Young
    Chon, Chae Yoon
    Han, Kwang-Hyub
    Park, Jun Yong
    HEPATOLOGY, 2010, 52 (04) : 504A - 504A
12345